Filing Details
- Accession Number:
- 0001773751-24-000158
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-04 16:19:06
- Reporting Period:
- 2024-05-31
- Accepted Time:
- 2024-06-04 16:19:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1773751 | Hims & Hers Health Inc. | HIMS | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1965903 | Michael Chi | 2269 Chestnut Street, #523 San Francisco CA 94123 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2024-05-31 | 2,300 | $6.82 | 178,972 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-05-31 | 2,300 | $20.20 | 176,672 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2024-05-31 | 393,881 | $5.01 | 570,553 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-05-31 | 345,423 | $19.34 | 225,130 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2024-05-31 | 48,458 | $20.17 | 176,672 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2024-06-03 | 101,962 | $6.82 | 278,634 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-06-03 | 101,962 | $21.00 | 176,672 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2024-06-03 | 19,141 | $6.82 | 195,813 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-06-03 | 19,141 | $20.35 | 176,672 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2024-06-03 | 4,096 | $5.01 | 180,768 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2024-06-03 | 4,096 | $20.34 | 176,672 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-05-31 | 2,300 | $0.00 | 2,300 | $6.82 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-05-31 | 393,881 | $0.00 | 393,881 | $5.01 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-06-03 | 101,962 | $0.00 | 101,962 | $6.82 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-06-03 | 19,141 | $0.00 | 19,141 | $6.82 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2024-06-03 | 4,096 | $0.00 | 4,096 | $5.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 346,132 | 2032-08-10 | No | 4 | M | Direct | |
| 436,682 | 2032-02-24 | No | 4 | M | Direct | |
| 244,170 | 2032-08-10 | No | 4 | M | Direct | |
| 225,029 | 2032-08-10 | No | 4 | M | Direct | |
| 432,586 | 2032-02-24 | No | 4 | M | Direct |
Footnotes
- The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024 by the Reporting Person.
- Includes 967 shares acquired on May 20, 2024, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.345. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.92 - $19.91. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.92 - $20.38. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.90. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.77. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on September 10, 2022, and 1/48th of the options vesting monthly thereafter.
- The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on March 24, 2022, and 1/48th of the options vesting monthly thereafter.
Billionaire Hedge Funds
